{"pending_diagnosis": "<b>DIAGNOSIS:</b>\n<span class=\"tg-spoiler\">Acute Intermittent Porphyria (AIP)</span>\n\n<b>THE SMOKING GUN:</b>\nThe constellation of symptoms (The \"Five Ps\"): <u>P</u>ain (severe abdominal), <u>P</u>olyneuropathy, <u>P</u>sychosis (acute confusion/hallucinations), <u>P</u>ink/Port wine urine, and <u>P</u>recipitating factors (the new oral contraceptive/hormone exposure). The critical observation was the <span class=\"tg-spoiler\">rapidly developing neuropathy combined with acute unexplained psychosis, severe autonomic dysfunction (Tachycardia/HTN), and the urine sample darkening upon exposure to light</span>.\n\n<b>PATHOPHYSIOLOGY:</b>\nAcute Intermittent Porphyria is an autosomal dominant disorder caused by a partial deficiency of the enzyme Porphobilinogen Deaminase (PBG-D), also known as Hydroxymethylbilane Synthase. This deficiency impairs the third step in the heme synthesis pathway.\n\nDuring an acute attack, precipitated by factors such as hormonal changes (OCPs), fasting, infection, or specific drugs, there is a massive accumulation of the neurotoxic precursors: Delta-aminolevulinic acid (ALA) and Porphobilinogen (PBG).\n\nThe severe abdominal pain is thought to be mediated by autonomic neuropathy affecting the visceral organs. The fluctuating hypertension and tachycardia are due to excess catecholamine release resulting from autonomic dysregulation. The peripheral neuropathy and acute psychosis/confusion are due to the direct neurotoxic effects of ALA and PBG on both the central and peripheral nervous systems. The <u>Hyponatremia</u> is common, often due to inappropriate ADH secretion (SIADH) resulting from CNS involvement. Confirmation is achieved by measuring highly elevated levels of ALA and PBG in the urine. Treatment involves high-dose intravenous glucose (to suppress the enzyme pathway) and, critically, intravenous Heme products (Hematin or Heme Arginate) to rapidly downregulate the production of the toxic precursors."}